Flexion Therapeutics, Inc.

ANQUEST

Pharmaceutical preparations, namely, pharmaceutical preparations for managing and relieving pain and inflammation; pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis; analgesic and anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for injection for medical purposes for the treatment of musculoskeletal conditions, soft tissue conditions and arthritis;AN QUEST;

ANQUEST

Pharmaceutical preparations, namely, pharmaceutical preparations for managing and relieving pain and inflammation; pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis; analgesic and anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for injection for medical purposes for the treatment of musculoskeletal conditions, soft tissue conditions and arthritis;

FLEXFORWARD

FLEX FORWARD;Providing information regarding insurance coverage by means of an online portal and call center; providing information regarding prescription drug insurance coverage for physicians and patients; administration of a patient assistance program for providing prescription drugs at reduced prices to patients, and providing information related thereto via a call center;Providing information in the field of prescription drug reimbursement by means of an online portal and a call center; providing information regarding prescription drug insurance costs and discounts for physicians and patients;Medical services, namely, providing a patient assistance program to provide prescription drugs at reduced prices to patients; providing medical information to patients via a call center regarding assistance programs for purchasing prescription drugs;

FLEXION

Research and development of pharmaceutical preparations, products and technology in the fields of musculoskeletal conditions, soft tissue conditions, and arthritis, and new therapies for pain, inflammation and functional impairment of joints; medical and scientific research and development in the fields of musculoskeletal conditions, soft tissue conditions, and arthritis, and new therapies for pain, inflammation and functional impairment of joints; providing medical and scientific research information in the fields of musculoskeletal conditions, soft tissue conditions, and arthritis, new therapies for pain, inflammation and functional impairment of joints; pharmaceuticals and clinical trials; scientific investigations for medical purposes; medical research;

FLEXION

Pharmaceutical preparations, namely, injectable pain therapeutics; pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis; analgesic and anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for injection for medical purposes for the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis;

FXTEND

Drug delivery agents in the form of dissolvable microspheres that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds, being a component in pharmaceutical preparations, that facilitate delivery of a wide range of pharmaceuticals;

FXTEND

Drug delivery agents in the form of dissolvable microspheres that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of hydrogel that facilitates the delivery of pharmaceutical preparations;F EXTEND;

TRELARTA

Pharmaceutical preparations, namely, pharmaceutical preparations for managing and relieving pain and inflammation; pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis; analgesic and anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for injection for medical purposes for the treatment of musculoskeletal conditions, soft tissue conditions and arthritis;The wording TRELARTA has no meaning in a foreign language.;

TRELARTA

Pharmaceutical preparations, namely, pharmaceutical preparations for managing and relieving pain and inflammation; pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis; analgesic and anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for injection for medical purposes for the treatment of musculoskeletal conditions, soft tissue conditions and arthritis;

Z

The mark consists of two lines of dots, side by side, in the shape of the letter Z.;Color is not claimed as a feature of the mark.;Research and development of pharmaceutical preparations, products and technology in the fields of musculoskeletal conditions, soft tissue conditions, and arthritis, and new therapies for pain, inflammation and functional impairment of joints; medical and scientific research and development in the fields of musculoskeletal conditions, soft tissue conditions, and arthritis, and new therapies for pain, inflammation and functional impairment of joints; providing medical and scientific research information in the fields of musculoskeletal conditions, soft tissue conditions, and arthritis, new therapies for pain, inflammation and functional impairment of joints; pharmaceuticals and clinical trials; scientific investigations for medical purposes; medical research;